Evidence map›Paper›PMID 27390513›Full record

ArticleMolecular vision2016

Pou4f2 knock-in Cre mouse: A multifaceted genetic tool for vision researchers.

Aaron B Simmons, Samuel J Bloomsburg, Samuel A Billingslea, Morgan M Merrill, Shuai Li, Marshall W Thomas, Peter G Fuerst

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Cholinergic Waves Have a Modest Influence on the Transcriptome of Retinal Ganglion Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  3. InducibleCells · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. DSCAM-mediated control of dendritic and axonal arbor outgrowth enforces tiling and inhibits synaptic plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aaron B SimmonsDepartment of Biological Sciences, University of Idaho, Moscow, ID.
Samuel J BloomsburgDepartment of Biological Sciences, University of Idaho, Moscow, ID.
Samuel A BillingsleaDepartment of Biological Sciences, University of Idaho, Moscow, ID.
Morgan M MerrillDepartment of Biological Sciences, University of Idaho, Moscow, ID.
Shuai LiDepartment of Biological Sciences, University of Idaho, Moscow, ID.
Marshall W ThomasDepartment of Biology, Brigham Young University-Idaho, Rexburg, ID.
Peter G FuerstDepartment of Biological Sciences, University of Idaho, Moscow, ID; WWAMI Medical Education Program, University of Washington School of Medicine, Moscow, ID.
University of Idaho · USBrigham Young University - Idaho · US

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Scott A Minnich · 2012 to 2026
$59.8M
UNDERGRADUATE COLLEGE OUTREACH PROGRAMP20RR016454 · NCRR · UNIVERSITY OF IDAHO · PI CHASE, JENNIFER R · 2001 to 2011
$35.3M
Genomics Resources Core (GRC)P30GM103324 · NIGMS · UNIVERSITY OF IDAHO · PI FORNEY, LARRY J · 2013 to 2017
$5.0M
Role of molecular recognition in retinal patterning and synaptic organizationR01EY020857 · NEI · UNIVERSITY OF IDAHO · PI FUERST, PETER GERARD · 2010 to 2014
$1.2M
NCRR NIH HHS P20 RR016454NEI NIH HHS R01 EY020857NIGMS NIH HHS P20 GM103408NIGMS NIH HHS P30 GM103324
6 · The paper itself

Abstract

purposeA transgenic mouse that expresses Cre recombinase under control of the Pou4f2-promoter (also referred to as Brn-3b and Brn-3.2) was characterized. Pou4f2 expression has been reported in a subset of retinal ganglion cells (RGCs) in the retina, in the midbrain, and in the germline. In this study, we characterize the expression pattern of this Cre-recombinase line and report its utility in targeted deletion, temporal deletion, RGC depletion, and germline targeting, which can be regulated by the sex of the Cre-carrying mouse.

methodsPou4f2(Cre) was mapped by using a combination of PCR and sequencing of PCR products to better understand the construct and to locate where it was inserted within the Pou4f2 locus. Cre expression patterns were examined by crossing Pou4f2(Cre/+) mice to Cre reporter mice. Immunohistochemistry was used to further define the pattern of Cre expression and Cre-mediated recombination within the retina, brain, and other tissues.

resultsAn internal ribosome entry site (IRES)-Cre cassette was inserted into the Pou4f2 gene disrupting normal gene function, as verified by the depletion of RGCs in mice homozygous for the insert. Pou4f2(Cre) expression was observed in the retina, brain, peripheral neurons, and male germ cells. Germline recombination was observed when the sire carried the Cre and the target for recombination. In all other breeding schemes, recombination was observed within subsets of cells within the retina, brain, intestines, heart, and gonads. In the retina, Cre efficiently targets recombination in neurons within the RGC layer (RGL), the inner nuclear layer (INL), and a small percentage of photoreceptors, activity that has not been previously reported. Unlike most other Cre lines active in the inner retina, recombination in Müller and other glia was not observed in mice carrying Pou4f2(Cre) . Within the visual centers of the brain, Cre targets recombination in about 15% of cells within the superchiasmatic nucleus, lateral geniculate nucleus, and superior colliculus.

conclusionsPou4f2(Cre) provides multiple uses for the vision researcher's genetic toolkit. First, Pou4f2(Cre) is a knock-in allele that can be used to eliminate Pou4f2, resulting in depletion of RGCs. Second, expression of Cre in male germ cells makes this strain an efficient germline activator of recombination, for example, to target LoxP-flanked sequences in the whole mouse. Third, Pou4f2(Cre) efficiently targets RGCs, amacrine cells, bipolar cells, horizontal cells, and a small number of photoreceptors within the retina, as well as the visual centers in the brain. Unlike other Cre recombinase lines that target retinal neurons, no recombination was observed in Müller or other retinal glia. These properties make this Cre recombinase line a useful tool for vision researchers.

Indexed as

Gene Knock-In TechniquesAllelesAnimalsBrainGene Expression RegulationHomeodomain ProteinsIntegrasesMaleMiceMice, Inbred C3HMice, Inbred C57BLMice, TransgenicMicroscopy, FluorescenceMolecular BiologyPolymerase Chain ReactionPromoter Regions, GeneticCre recombinaseHomeodomain ProteinsIntegrasesPou4f2 protein, mouseTranscription Factor Brn-3B

Identifiers

PMID27390513
PMCPMC4919092
OpenAlexW2468336005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.